Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD finger protein 21A is a chromatin-binding transcription coregulator involved in the repression of neuron-specific gene expression in non-neuronal cells. It functions as a component of the BRAF35/HDAC2 (BHC) corepressor complex, mediating histone demethylation and deacetylation at specific promoters, particularly through interaction with unmethylated histone H3 lysine 4. PHF21A plays an essential regulatory role in neurodevelopment and craniofacial formation. Loss of PHF21A due to genetic deletion is linked to Potocki-Shaffer syndrome, intellectual disability, and related developmental disorders. PHF21A interacts with proteins including HDAC1, Histone deacetylase 2, HMG20B, and RCOR1, further emphasizing its central role in epigenetic regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD finger protein 21A (PHF21A).